Related Experiment Video
Updated: Apr 27, 2026
10:24
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
Published on: June 11, 2015
12.8K
Platelets, cyclooxygenases, and colon cancer
Paloma Guillem-Llobat1, Melania Dovizio1, Sara Alberti1
1Department of Neuroscience, Imaging and Clinical Sciences (Section of Cardiovascular and Pharmacological Sciences) and Center of Excellence on Aging (CeSI), "G. d'Annunzio" University, Chieti, Italy.
Seminars in Oncology
|July 16, 2014
Summary
Platelets play a key role in cancer development and spread. Aspirin, an antiplatelet drug, shows anti-cancer effects by inhibiting platelet cyclooxygenase (COX) activity, suggesting new therapeutic avenues.
Area of Science:
- Oncology
- Hematology
- Inflammation research
Background:
- Platelets are increasingly recognized for their role in early cancer development and metastasis.
- Platelet activation triggers inflammation via cyclooxygenase (COX)-2 and prostaglandin E2, promoting tumor growth.
- Clinical studies show aspirin's anti-cancer efficacy, even at low doses, linked to its antiplatelet action.
Purpose of the Study:
- To explore the central role of platelets in tumorigenesis and metastasis.
- To investigate the anti-cancer mechanisms of aspirin related to platelet inhibition.
- To identify novel therapeutic strategies targeting platelet-cancer interactions.
Main Methods:
- Analysis of existing clinical studies on aspirin's anti-cancer effects.
- Review of experimental evidence on platelet activation and inflammation in cancer.
- Identification of molecular pathways involved in platelet-tumor cell crosstalk.
Main Results:
- Platelet activation promotes a proinflammatory state that supports tumorigenesis.
- Aspirin inhibits platelet cyclooxygenase (COX)-1, reducing thromboxane A2 synthesis and exerting anti-cancer effects.
- Evidence suggests a significant link between platelet activity and cancer progression.
Conclusions:
- Platelets are critical players in cancer initiation and metastasis.
- Targeting platelet activation, potentially with agents like aspirin, offers a promising strategy for cancer prevention and treatment.
- Further research into platelet-tumor cell interactions may reveal novel oncology therapeutics.
More Related Videos
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.6K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.6K
01:18Structure and Function of Platelets
6.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.8K